Strickland, S., Wang, E., Ball, B., Mims, A., Zeidner, J., Wang, X., Shallis, R., Lai, C., Yen, K., Millan, D., DeBartolo, J., Neef, J., Antipov, L., Manyak, E., Kendrick, R., Peng, G., Straley, K., Almon, C., Brownstein, C., DiNardo, C. (2025). A phase 1 dose escalation and dose optimization study to evaluate the preliminary safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical activity profile of AUTX703 in participants with relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. Blood. https://doi.org/10.1182/blood-2025-6952